Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ULTRALIFE CORP Director's Dealing 2020

Nov 24, 2020

34105_dirs_2020-11-24_8c3424f7-82a2-4ff5-b219-633286a0b71e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ULTRALIFE CORP (ULBI)
CIK: 0000875657
Period of Report: 2020-11-23

Reporting Person: POPIELEC MICHAEL D (Director, Director, President and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-11-23 Common Stock; $.10 par value M 26929 $6.4218 Acquired 297217 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-11-23 Stock Options $6.4218 M 300000 Disposed 2020-12-30 Common Stock (300000) Direct

Footnotes

F1: (1) Represents shares of common stock acquired by the Reporting Person upon exercise of options for 300,000 shares of common stock of the Company, net of 273,071 shares of common stock retained by the Company at a price determined pursuant to the terms of the Company's 2004 Long Term Incentive Plan in payment of the exercise price for the options and the Reporting Person's individual minimum statutory withholding tax obligation.

F2: (2) Represents exercise of options for 300,000 shares of common stock of the Company otherwise expiring on 12/30/2020.